MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹381 Cr | ₹314 Cr | ₹266 Cr | ₹185 Cr | ₹236 Cr |
What is the latest Consolidated Net Profit of MARKSANS PHARMA ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2026 | ₹381 Cr |
| Mar2025 | ₹314 Cr |
| Mar2024 | ₹266 Cr |
| Mar2023 | ₹185 Cr |
| Mar2022 | ₹236 Cr |
How is Consolidated Net Profit of MARKSANS PHARMA Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2026 | ₹381 Cr | 21.32 | |
| Mar2025 | ₹314 Cr | 17.80 | |
| Mar2024 | ₹266 Cr | 44.29 | |
| Mar2023 | ₹185 Cr | -21.77 | |
| Mar2022 | ₹236 Cr | - | |
Compare Consolidated Net Profit of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹13,831.7 Cr | 3.7% | -9.4% | 66.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | 3.7% |
-9.4% |
66.5% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses